THORACIC VASCULAR STENT GRAFT MARKET VALUED USD 250 MN SEEN SOARING 6% GROWTH BY 2030, PROJECTS UNIVDATOS MARKET INSIGHTS

The Thoracic Vascular Stent Graft Market was valued at USD 250 million in the year 2022 and is expected to grow at a strong CAGR of around 6% during the forecast period. In recent years, there has been a significant rise in the demand for thoracic vascular stent graft. This article delves into the burgeoning demand of thoracic vascular stent graft, its applications, etc.

Thoracic Vascular Stent Graft Demand in the Global Market

The demand for Thoracic Vascular Stent Graft has witnessed a significant upswing in recent years. One significant factor is the increasing prevalence of thoracic aortic aneurysms, which can be attributed to factors such as an aging population and lifestyle choices. The awareness and diagnosis of these conditions have also improved, leading to a higher demand for treatment options. For Instance, as per the data of the Centre of Disease Control and Prevention, about 2% of the US Population has valvular disease.

Advancements in medical technology and surgical techniques have made thoracic vascular stent grafts a more viable and effective treatment option. This has further contributed to the increasing demand as patients and healthcare professionals recognize the benefits of these devices, such as reduced invasiveness and faster recovery compared to traditional open surgeries.

The rise in demand for thoracic vascular stent grafts has led to a competitive market landscape, with several key players in the medical device industry focusing on the development and commercialization of these products. This competition encourages manufacturers to improve their offerings and invest in marketing efforts, further driving the market’s growth.

Fig1: Global Aortic Aneurysms, 2020-2030, Million

Applications of Thoracic Vascular Stent Graft

1. Aortic Aneurysms: Thoracic vascular stent grafts are commonly used to treat aortic aneurysms, which are bulging or weakened areas in the aorta. The stent graft is inserted into the affected area to reinforce and support the weakened vessel walls, preventing the risk of rupture.

2. Aortic Dissections: Aortic dissections occur when there is a tear in the inner layer of the aorta, causing blood to flow between the layers and potentially leading to life-threatening complications. Stent grafts can be deployed in this scenario to seal off the tear and restore proper blood flow.

3. Traumatic Injuries: In cases of traumatic injuries to the thoracic aorta, such as in accidents or blunt trauma, stent-grafts may be used to repair the damaged vessel and restore blood flow.

4. Aortic Stenosis: Thoracic vascular stent grafts can also be utilized to treat aortic stenosis, a condition characterized by the narrowing of the aortic valve. By expanding the narrowed valve using a stent graft, blood flow can be improved.

5. Type B Aortic Dissections: Type B aortic dissections involve tears in the descending part of the aorta. Stent grafts can be used to redirect blood flow and promote healing in these cases.

For More Detailed Analysis in PDF Format, Visit- https://univdatos.com/report/thoracic-vascular-stent-graft-market/

Recent Developments/Awareness Programs: – Several key players and governments are rapidly adopting strategic alliances and recent product launches are supplementing the growth of the market.

• In May 2022, GORE TAG Thoracic Branch Endoprosthesis (TBE) got FDA approval for the aorticaneurysm, transection, and dissection.
• In 2021, Terumo Aortic’s Relay®Pro Thoracic Stent Graft received FDA approval for the treatment of patients with Thoracic Aortic Aneurysms (TAA) and Penetrating Atherosclerotic Ulcers (PAUs).
• In May 2023, Terumo Aortic announced the US FDA approval of the Relay®Pro Thoracic Stent-Graft device for the treatment of dissection and transection.

Conclusion

In conclusion, the increasing demand for thoracic vascular stent grafts reflects the recognition of their effectiveness in treating complex thoracic aortic pathologies. As technology continues to advance and more patients become aware of the benefits, we can expect further growth in the adoption of these life-saving devices. With ongoing research and development efforts, the future of thoracic vascular stent grafts looks promising in revolutionizing the treatment landscape for cardiovascular diseases.

Key Offerings of the Report

Market Size, Trends, & Forecast by Revenue | 2023−2030.

Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities

Market Segmentation – A detailed analysis by Fuel Type and Application

Competitive Landscape – Top Key Vendors and Other Prominent Vendors